- Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
-
Kwok SK
- KMID: 1794621
- Korean J Intern Med.
- 2014 Sep;29(5):577-579.
- doi: 10.3904/kjim.2014.29.5.577
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Utilization Patterns of Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients
-
Jin XM, Lee J, Choi NK, Seong JM, Shin JY, Kim YJ, Kim MS, Yang BR, Park BJ
- KMID: 1789977
- J Korean Med Sci.
- 2014 Feb;29(2):210-216.
- doi: 10.3346/jkms.2014.29.2.210
This study was conducted to investigate disease-modifying antirheumatic drug (DMARD) utilization in Korean elderly patients with rheumatoid arthritis (RA). We used data from January 1, 2005 to June 30, 2006... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Progressive Rheumatoid Interstitial Lung Disease With Cyclosporine: A Case Report
-
Chang HK, Park W, Ryu DS
- KMID: 648690
- J Korean Med Sci.
- 2002 Apr;17(2):270-273.
- doi: 10.3346/jkms.2002.17.2.270
Treatment of interstitial lung disease (ILD) in rheumatoid arthritis (RA) has been controversial. Although there have been several anecdotal reports on the efficacies of corticosteroids or cytotoxic agents such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug Survival Rates of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
-
Kang JH, Park DJ, Lee JW, Lee KE, Wen L, Kim TJ, Park YW, Lee SS
- KMID: 1794597
- J Korean Med Sci.
- 2014 Sep;29(9):1205-1211.
- doi: 10.3346/jkms.2014.29.9.1205
We investigated the compliance of Korean patients using tumor necrosis factor (TNF) inhibitors to treat rheumatoid arthritis (RA) and ankylosing spondylitis (AS), and identified potential predictors associated with treatment discontinuation.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Trial and Extension Study of Infliximab in Korean Patients with Active Rheumatoid Arthritis despite Methotrexate Treatment
-
Kim J, Ryu H, Yoo DH, Park SH, Song GG, Park W, Cho CS, Song YW
- KMID: 1779410
- J Korean Med Sci.
- 2013 Dec;28(12):1716-1722.
- doi: 10.3346/jkms.2013.28.12.1716
Currently, infliximab is given for disease control for active rheumatoid arthritis (RA) patients despite methotrexate treatment. However, the efficacy and safety of infliximab in Korean patients has not been assessed... -
- CITED
-
- Close
- SHARE
-
- Close
- Infliximab Partially Alleviates the Bite Force Reduction in a Mouse Model of Temporomandibular Joint Pain
-
Kim SH, Son CN, Lee HJ, Cho HC, Jung SW, Hur JA, Baek WK, Jung HR, Hong JH
- KMID: 2155467
- J Korean Med Sci.
- 2015 May;30(5):552-558.
- doi: 10.3346/jkms.2015.30.5.552
Temporomandibular joint (TMJ) disorder is clinically important because of its prevalence, chronicity, and therapy-refractoriness of the pain. In this study, we investigated the effect of infliximab in a mouse model... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis
-
Novikova D, Popkova TV, Lukina GV, Luchikhina EL, Karateev D, Volkov AV, Novikov AA, Aleksandrova EN, Nasonov EL
- KMID: 2360043
- J Korean Med Sci.
- 2016 Feb;31(2):202-207.
- doi: 10.3346/jkms.2016.31.2.202
The aim of the study was to examine lipid profiles, arterial stiffness (AS), carotid intima-media thickness (cIMT), in 55 women with RA without overt cardiovascular disease (capital ES, CyrillicVD) treated... -
- CITED
-
- Close
- SHARE
-
- Close
